Literature DB >> 2843753

Release of a virus coded glycoprotein from herpes simplex virus type 1 infected cells.

K H Tiedemann1, H Hampl, K O Habermehl.   

Abstract

HEp-2 cells, which were infected with HSV-1, excrete besides other proteins a soluble glycoprotein (Mr 125,000-130,000) related to the virus protein gC. The excretion of the glycoprotein and the production of extracellular virus particles is reduced to a similar extent when the cells were treated with monensin. Possible consequences of the excretion of soluble viral proteins to a modulation of the immune response are discussed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2843753     DOI： 10.1007/BF00805636

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN： 0301-4851            Impact factor:   2.316


  24 in total

1.  Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis.

Authors:  A B Chen; T Ben-Porat; R J Whitley; A S Kaplan
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

2.  Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein.

Authors:  R J Isfort; R A Stringer; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Proceedings: Escape from immune destruction by the host through shedding of surface antigens: is this a characteristic shared by malignant and embryonic cells?

Authors:  P Alexander
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells.

Authors:  D C Johnson; P G Spear
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

6.  Role of antibody in primary and recurrent herpes simplex virus infection.

Authors:  A Simmons; A A Nash
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

Review 7.  Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis.

Authors:  B F Vestergaard
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

8.  Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.

Authors:  S Kohl; L S Loo
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

9.  Differences in the morphology of herpes simplex virus infected cells. II. Type specific membrane alterations of HSV-1 and HSV-2 infected cells.

Authors:  H Hampl; J R Schlehofer; K O Habermehl
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

10.  Export of major cell surface proteins is blocked in yeast secretory mutants.

Authors:  P Novick; R Schekman
Journal:  J Cell Biol       Date:  1983-02       Impact factor: 10.539
View more
  1 in total

1.  Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism.

Authors:  Lenka Sedlackova; Keith D Perkins; Joy Lengyel; Anna K Strain; Vicky L van Santen; Stephen A Rice
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.